SYMPTOMATIC VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT
نویسندگان
چکیده
منابع مشابه
Symptomatic venous thromboembolism after total knee replacement.
Chemical prophylaxis is known to reduce the venographic prevalence of deep-vein thrombosis (DVT) after total knee replacement (TKR), but it is uncertain whether this affects the incidence of symptoms. Further analysis depends on the basic epidemiology of thromboembolic symptoms. We therefore studied the pattern of such symptoms in a consecutive series of 1000 patients with primary TKR, with par...
متن کاملPrevention of venous thromboembolism in total knee and hip replacement.
Case presentation: A 69-year-old woman had a cemented hip replacement 15 years previously, which initially fared well but then gradually failed because of aseptic loosening. She developed pain in her hip and was scheduled for a revision total hip replacement. A formal venous thromboembolism (VTE) risk assessment was undertaken before surgery according to the Hospital’s policy for all orthopedic...
متن کاملOral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
A once-daily dose of rivaroxaban 10 mg, an oral, direct Factor Xa inhibitor, was compared with enoxaparin 40 mg subcutaneously once daily for prevention of venous thromboembolism in three studies of patients undergoing elective hip and knee replacement (RECORD programme). A pooled analysis of data from these studies (n = 9581) showed that rivaroxaban was more effective than enoxaparin in reduci...
متن کاملApixaban for the Prevention of Thromboembolism in Adults after Elective Hip or Knee Replacement Surgery, and in Symptomatic Venous Thromboembolism
The anticoagulant effect of apixaban is due to direct inhibition of FXa in the coagulation cascade. The main advantages apixaban has over the current anti-coagulant drugs is that it is active after oral administration, and its coagulation effect does not require monitoring. Apixaban has been compared to enoxaparin in the prevention of venous thromboembolism associated with knee and hip replacem...
متن کاملPrevention of venous thromboembolism after total hip and knee arthroplasty.
Venous Thromboembolism (VTE) remains a clinical threat to orthopaedic surgeons, despite of a large number of clinical trials and research performed on this subject. Various guidelines and recommendations are available in clinical practice but the search continues for an ideal agent or combination of agents for VTE prophylaxis. Rudolf Virchow first described Deep Vein Thrombosis (DVT) and the su...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Bone and Joint Surgery. British volume
سال: 1997
ISSN: 0301-620X,2044-5377
DOI: 10.1302/0301-620x.79b5.0790780